PharmAthene UK Limited This study has been completed. Phase II
Last Updated September 12, 2008
PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration http://www.genengnews.com/news/bnitem.aspx?name=41875418
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.